To access the status of SINGULAIR on selected formularies using this tool, simply select your state from the drop-down menu.

If a managed care organization is not named in Table 1, be sure to check Table 2 for that managed care organization.

Please note, lower acquisition costs do not necessarily reflect a cost advantage in the outcome of the condition treated. In addition, comparison of the copays is in no way a comparison of safety or efficacy of the products.

Select a state from the following list: Choose a state ALABAMA ALASKA ARIZONA ARKANSAS CALIFORNIA COLORADO CONNECTICUT DELAWARE DISTRICT OF COLUMBIA FLORIDA GEORGIA HAWAII IDAHO ILLINOIS INDIANA IOWA KANSAS KENTUCKY LOUISIANA MAINE MARYLAND MASSACHUSETTS MICHIGAN MINNESOTA MISSISSIPPI MISSOURI MONTANA NEBRASKA NEVADA NEW HAMPSHIRE NEW JERSEY NEW MEXICO NEW YORK NORTH CAROLINA NORTH DAKOTA OHIO OKLAHOMA OREGON PENNSYLVANIA PUERTO RICO RHODE ISLAND SOUTH CAROLINA SOUTH DAKOTA TENNESSEE TEXAS UTAH VERMONT VIRGINIA WASHINGTON WEST VIRGINIA WISCONSIN WYOMING

Glossary (for your patients):

On Formulary: The product is available on the approved list of drugs for the Health Maintenance Organization (HMO)/Pharmacy Benefit Manager (PBM). If a product is not on formulary, the plan will not cover the cost of the drug unless medically necessary and the formulary products have been tried.

Preferred Drug List (PDL): Those formulary drugs that the HMO/PBM strongly encourages their members to use. Depending on benefit design, the encouragement may be in the form of lower copay or there may be strict criteria that must be met before nonpreferred products may be used. Depending on the plan, sometimes the term PDL and formulary are used interchangeably.

On National Formulary: A PBM manages the prescription benefits for many health plans. Most of the plans follow the PBM's overall or National Formulary. There may be a few plans that have made separate agreements to follow a different formulary, but these are normally the exception.

Tiered Copay Pharmacy Benefit: In a tiered benefit, the copay a person pays for a drug on formulary is dependent on what tier it is in. Typically, Tier 1 is the lowest copay ($0–$10) and consists mainly of generic drugs. Tier 2 is a slightly higher copay ($10–$25) and normally represents the branded drugs on formulary that the HMO/PBM prefers the member to use. Tier 3 is a higher copay ($15–$50) and is normally those products the HMO/PBM does not prefer or special use drugs. Some plans use a 4- or 5-tier benefit, which uses a concept similar to the 3-tier benefit.

Covered, Tier 3: The HMO/PBM will provide reimbursement for the product, but the member must pay a Tier 3 copay. (See Tiered Copay Pharmacy Benefit.)

On Formulary, Tier 2: The product is available on the approved list of drugs for the HMO/PBM and the member must pay a Tier 2 copay. (See Tiered Copay Pharmacy Benefit.)

On Formulary, Tier 3: The product is available on the approved list of drugs for the HMO/PBM and the member must pay a Tier 3 copay. (See Tiered Copay Pharmacy Benefit.)

On Formulary, Exclusive, Tier 2: The product is the only formulary drug that is available with a Tier 2 copay. If there is no product in Tier 1 for this class, from a copay perspective, this is the lowest-priced drug a member could receive for this class. (See Tiered Copay Pharmacy Benefit.)

Exception Language: The drug is normally not covered or reimbursed unless certain criteria are met. The wording of the criteria for getting an exception is often called the Exception Language. You must contact your plan administrator for guidance.